ORMP · Oramed Pharmaceuticals Inc.
$3.97
-0.20 (-4.80%)
At close · Jul 29
Market Cap
$170.66M
Shares
40.93M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-30 | 2026-06-25 | |
| 10-Q | 2026-05-19 | 2026-03-31 | |
| 8-K | 2026-03-31 | 2026-03-25 | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-02-20 | 2026-02-19 | |
| 8-K | 2026-01-14 | 2026-01-12 | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2025-12-31 | 2025-12-30 | |
| 8-K | 2025-12-31 | — | |
| 8-K | 2025-11-17 | — | |
| 8-K | 2025-11-17 | 2025-11-16 | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-10-24 | 2025-10-20 | |
| 8-K | 2025-10-06 | 2025-09-30 | |
| 8-K | 2025-08-21 | 2025-08-19 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-07-23 | 2025-07-22 | |
| DEF 14A | 2025-07-16 | 2025-08-19 | |
| 10-K/A | 2025-07-16 | 2024-12-31 | |
| 8-K | 2025-05-21 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-04-28 | 2025-04-24 | |
| 10-K | 2025-03-27 | 2024-12-31 | |
| 8-K | 2025-03-03 | 2025-02-28 | |
| 8-K | 2025-02-27 | 2025-02-22 | |
| 8-K | 2025-02-11 | 2025-02-07 | |
| 8-K | 2025-01-22 | 2025-01-21 | |
| 8-K | 2025-01-03 | 2025-01-02 | |
| 8-K | 2024-12-17 | 2024-12-13 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-10-29 | 2024-10-24 | |
| 8-K | 2024-10-08 | 2024-10-07 | |
| 8-K | 2024-09-26 | 2024-09-23 | |
| 8-K | 2024-09-23 | 2024-09-20 | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-02 | 2024-08-01 | |
| 8-K | 2024-06-26 | — | |
| 8-K | 2024-06-24 | 2024-06-20 | |
| DEF 14A | 2024-06-20 | 2024-08-01 | |
| 8-K | 2024-06-10 | 2024-06-06 | |
| 8-K | 2024-05-13 | 2024-05-10 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-06 | 2024-05-02 | |
| 8-K | 2024-03-19 | 2024-03-14 | |
| 8-K | 2024-03-18 | 2024-03-12 | |
| 8-K | 2024-03-18 | — | |
| 10-K | 2024-03-06 | 2023-12-31 | |
| 8-K | 2024-02-20 | — | |
| 8-K | 2024-01-23 | 2024-01-22 | |
| 8-K | 2024-01-19 | 2024-01-17 |
Showing 1–50 of 118 filings
Key facts
CIK
1176309
CUSIP
68403P203
13F (30d)
11 filings
11 filers
Visit website
Investor relations